These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 15767726)

  • 21. Serological correlations with nephritis in systemic lupus erythematosus.
    Reichlin M
    Clin Immunol; 2005 Oct; 117(1):12-4. PubMed ID: 16006192
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Antihistones antibodies in systemic lupus erythematosus, comparison of three assays: Elisa, dot blot and immunoblot].
    Ghedira I; Landolsi H; Mankai A; Fabien N; Jeddi M
    Pathol Biol (Paris); 2006 Apr; 54(3):148-54. PubMed ID: 16169158
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antineuroblastoma antibodies in systemic lupus erythematosus.
    Danon YL; Garty BZ; Nitzan M
    Isr J Med Sci; 1984 Aug; 20(8):720-1. PubMed ID: 6469598
    [No Abstract]   [Full Text] [Related]  

  • 24. Anti-C1q antibodies in juvenile-onset systemic lupus erythematosus.
    Jesus AA; Silva CA; Carneiro-Sampaio M; Sheinberg M; Mangueira CL; Marie SK; Liphaus BL
    Ann N Y Acad Sci; 2009 Sep; 1173():235-8. PubMed ID: 19758156
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Passive hemagglutination assay for detection & quantitation of autoantibodies reactive with thymus RNA in systemic lupus erythematosus.
    Kumar A; Malaviya AN; Ali R
    Indian J Biochem Biophys; 1983 Oct; 20(5):304-5. PubMed ID: 6202622
    [No Abstract]   [Full Text] [Related]  

  • 26. Anti-chromatin and anti-C1q antibodies in systemic lupus erythematosus compared to other systemic autoimmune diseases.
    Braun A; Sis J; Max R; Mueller K; Fiehn C; Zeier M; Andrassy K
    Scand J Rheumatol; 2007; 36(4):291-8. PubMed ID: 17763207
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Th1/Th2 balance of SLE patients with lupus nephritis.
    Nakashima H; Akahoshi M; Masutani K
    Rinsho Byori; 2006 Jul; 54(7):706-13. PubMed ID: 16913661
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Longterm clinical and immunological effects of anti-CD20 treatment in patients with refractory systemic lupus erythematosus.
    Lindholm C; Börjesson-Asp K; Zendjanchi K; Sundqvist AC; Tarkowski A; Bokarewa M
    J Rheumatol; 2008 May; 35(5):826-33. PubMed ID: 18398943
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High prevalence of anti-C1q antibodies in biopsy-proven active lupus nephritis.
    Trendelenburg M; Lopez-Trascasa M; Potlukova E; Moll S; Regenass S; Frémeaux-Bacchi V; Martinez-Ara J; Jancova E; Picazo ML; Honsova E; Tesar V; Sadallah S; Schifferli J
    Nephrol Dial Transplant; 2006 Nov; 21(11):3115-21. PubMed ID: 16877491
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HL-A and systemic lupus erythematosus.
    Stenszky V; Szegedi G; Aszódi L; Petrányi G
    Haematologia (Budap); 1973; 7(2):211-7. PubMed ID: 4789725
    [No Abstract]   [Full Text] [Related]  

  • 31. Juvenile onset Systemic Lupus Erythematosus thyroid dysfunction: a subgroup with mild disease?
    Parente Costa L; Bonfá E; Martinago CD; de Oliveira RM; Carvalho JF; Pereira RM
    J Autoimmun; 2009 Sep; 33(2):121-4. PubMed ID: 19419839
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Antineural antibodies in patients with systemic lupus erythematosus].
    Schmidt RE; Ryan PF; Hughes GR; Stroehmann I
    Med Welt; 1981 Aug; 32(32-33):1216-8. PubMed ID: 7024709
    [No Abstract]   [Full Text] [Related]  

  • 33. Increased risk of complete congenital heart block in infants born to women with hypothyroidism and anti-Ro and/or anti-La antibodies.
    Spence D; Hornberger L; Hamilton R; Silverman ED
    J Rheumatol; 2006 Jan; 33(1):167-70. PubMed ID: 16292791
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Lupus nephritis as a factor of atherosclerosis risk in patients with systemic lupus erythematosus].
    Serikova SIu; Kozlovskaia NL; Shilov EM
    Ter Arkh; 2008; 80(6):52-8. PubMed ID: 18655477
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Autoantibodies in lupus nephritis patients requiring renal transplantation.
    Stinton LM; Barr SG; Tibbles LA; Yilmaz S; Sar A; Benedikttson H; Fritzler MJ
    Lupus; 2007; 16(6):394-400. PubMed ID: 17664229
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Tissue antibodies in systemic lupus erythematosus].
    Mitu S; Purice S; Matei I; Guran M; Cernescu C
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1980; 32(2):159-64. PubMed ID: 6107979
    [No Abstract]   [Full Text] [Related]  

  • 37. High dose intravenous immunoglobulins: a new step in the treatment of systemic lupus erythematosus.
    Rauova L; Rovensky J; Shoenfeld Y
    Isr Med Assoc J; 2000 May; 2(5):388-92. PubMed ID: 10892397
    [No Abstract]   [Full Text] [Related]  

  • 38. Elevated serum anti-endothelial cell autoantibodies titer is associated with lupus nephritis in patients with systemic lupus erythematosus.
    Tseng JC; Lu LY; Hu RJ; Kau CK; Cheng HH; Lin PR; Sun CW; Liang HT; Lam HC; Tai MH
    J Microbiol Immunol Infect; 2007 Feb; 40(1):50-5. PubMed ID: 17332907
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The relationship of desoxyribonuclease inhibitor levels in human sera to the occurrence of antinuclear antibodies.
    Frost PG; Lachmann PJ
    Clin Exp Immunol; 1968 Jun; 3(5):447-55. PubMed ID: 5662583
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevalence of thyroid dysfunction in systemic lupus erythematosus.
    Appenzeller S; Pallone AT; Natalin RA; Costallat LT
    J Clin Rheumatol; 2009 Apr; 15(3):117-9. PubMed ID: 19300286
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.